Comparison of sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce cardiovascular and renal outcomes: a network meta-analysis of randomized controlled trials

被引：0
|
作者：
Kani, R. [1 ]
Watanabe, A. [2 ]
Miyamoto, Y. [3 ]
Kuno, T. [4 ]
机构：
[1] Kameda Med Ctr, Kamogawa, Japan
[2] Univ Tsukuba, Div Hosp Med, Ibaraki, Japan
[3] Ctr Dis Control & Prevent, Div Diabet Translat, Surveillance Econ & Stat Branch, Atlanta, GA USA
[4] Albert Einstein Coll Med, Div Cardiol, Montefiore Med Ctr, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature
    Mani, Sweatha
    Balasubramanian, Abirami
    Veluswami, Keerthana
    Rao, Sudipta
    Aggarwal, Shailesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [2] Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials
    Spiazzi, Bernardo F.
    Naibo, Rafaella A.
    Wayerbacher, Laura F.
    Piccoli, Giovana F.
    Farenzena, Laura P.
    Londero, Thiza M.
    da Natividade, Gabriella R.
    Zoldan, Maira
    Degobi, Nathalia A. H.
    Niches, Matheus
    Lopes, Gilberto
    Boyko, Edward J.
    Utzschneider, Kristina M.
    Colpani, Veronica
    Gerchman, Fernando
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 198
  • [3] The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials
    Buttice, Leonardo
    Ghani, Maryam
    Suthakar, Janahan
    Gnanalingham, Sathyan
    Carande, Elliott
    Kennedy, Brett W. C.
    Pitcher, Alex
    Gamble, James H. P.
    Ahmad, Mahmood
    Lewis, Andrew
    Juni, Peter
    Rider, Oliver J.
    Stephens, Jeffrey W.
    Bray, Jonathan J. H.
    DIABETES OBESITY & METABOLISM, 2024, 26 (07): : 2706 - 2721
  • [4] Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
    Yao Neng Teo
    Adriel Z. H. Ting
    Yao Hao Teo
    Elliot Yeung Chong
    Joshua Teik Ann Tan
    Nicholas L. Syn
    Alys Z. Q. Chia
    How Ting Ong
    Alex Jia Yang Cheong
    Tony Yi-Wei Li
    Kian Keong Poh
    Tiong Cheng Yeo
    Mark Yan-Yee Chan
    Raymond C. C. Wong
    Ping Chai
    Ching-Hui Sia
    American Journal of Cardiovascular Drugs, 2022, 22 : 299 - 323
  • [5] Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials
    Teo, Yao Neng
    Ting, Adriel Z. H.
    Teo, Yao Hao
    Chong, Elliot Yeung
    Tan, Joshua Teik Ann
    Syn, Nicholas L.
    Chia, Alys Z. Q.
    Ong, How Ting
    Cheong, Alex Jia Yang
    Li, Tony Yi-Wei
    Poh, Kian Keong
    Yeo, Tiong Cheng
    Chan, Mark Yan-Yee
    Wong, Raymond C. C.
    Chai, Ping
    Sia, Ching-Hui
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 299 - 323
  • [6] The impact of sodium-glucose Cotransporter-2 inhibitors on lipid profile: A meta-analysis of 28 randomized controlled trials
    Fan, Gang
    Guo, Dian long
    Zuo, Hong
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2023, 959
  • [7] Risk of hypovolemia associated with sodium-glucose cotransporter-2 inhibitors treatment: A meta-analysis of randomized controlled trials
    Rong, Xi
    Zhu, Yawen
    Wen, Bo
    Liu, Kai
    Li, Xinran
    Gou, Qiling
    Chen, Xiaoping
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Sodium-Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials
    Ibrahim, Sammudeen
    Chinnatambi, Christopher
    Osman, Abdul-Fatawu
    Addo, Basilio
    Allihien, Saint-Martin
    Ozaeta, Jan Camille
    Kesiena, Onoriode
    Singireddy, Shreyas
    Amoateng, Richard
    Ahmed, Ibrahim
    CIRCULATION, 2024, 150
  • [9] Prevention of cardiovascular disease and renal failure in type 2 diabetes: sodium-glucose cotransporter-2 (SGLT2) inhibitors
    O'Sullivan, Jack W.
    BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (02) : 79 - 80
  • [10] Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: A Meta-Analysis of Randomized Clinical Trials
    Kumar, Kris
    Kheiri, Babikir
    Simpson, Timothy F.
    Osman, Mohammed
    Rahmouni, Hind
    AMERICAN JOURNAL OF MEDICINE, 2020, 133 (11): : E625 - E630
12345